In the present study, two fundamentally different, and commonly applied, approaches to assess p53 nuclear expression were evaluated as predictors of PCa progression, namely intensity (0, 1+, 2+, 3+) observed and percentage (0%, <1%, 1–5%, and >5%) of tumor cells expressing any level of intensity. The gene discussed is TP53; the disease is neoplasm.